Literature DB >> 21825928

Impact of enhanced mobilization of bone marrow derived cells to site of injury.

Edward J Hannoush1, Ziad C Sifri, Ihab O Elhassan, Alicia M Mohr, Walter D Alzate, Michael Offin, David H Livingston.   

Abstract

BACKGROUND: Bone marrow derived cells (BMDC) and mesenchymal stem cells (MSC) are necessary for healing of injured tissues. Intravenous granulocyte-colony stimulating factor (G-CSF) is known to induce mobilization of BMDC to peripheral blood and the tissue levels of the stromal cell derived factor-1 (SDF-1) to be key in their homing to sites of injury. We hypothesized that injection of SDF-1 to the site of injury and/or systemic administration of G-CSF increases homing of BMDC and improves healing of traumatic injury. We also postulated that increased homing of MSC alone to sites of injury would also improve tissue healing.
METHODS: Male Sprague-Dawley rats were subjected to unilateral lung contusion (LC) and assigned to the following groups: LC + injection of SDF-1 (LC + SDF-1) in the contused lung, pretreatment with systemic G-CSF for 5 days followed by either LC alone (LC + G-CSF) or by LC + injection of SDF-1 (LC + SDF-1/G-CSF). Rats in the MSC group were subjected to LC followed by systemic injection of MSC (LC + MSC). Unmanipulated controls and LC + local injection of saline (LC + saline) served as controls. Lung injury was assessed on days 1 and 5 postinjury using a histologic Lung Injury Score. BMDC and MSC homing were assessed on day 1 by hematopoietic progenitor cell (CFU-GEMM, BFU-E, and CFU-E) colony growth and immunofluorescence tracking of tagged MSC in the injured lung, respectively.
RESULTS: Both LC + SDF-1 and LC + G-CSF had increased hematopoietic progenitor cell colony growth in the injured lung, and their combination (LC + SDF-1/G-CSF) was additive when compared with LC + saline (18 ± 3, 24 ± 3, 32 ± 3; 21 ± 3, 36 ± 10, 36 ± 3; 31 ± 4, 44 ± 10, 53 ± 5 vs. 6 ± 2, 11 ± 3, 17 ± 4; *p < 0.05). Tagged MSC were tracked predominantly in the contused lung versus the non-contused lung (7 ± 3 vs. 3 ± 2, N° MSC/HPF; *p < 0.05). Lung Injury Score on day 5 after injury was significantly lower in the LC + SDF-1, LC + G-CSF, LC + SDF-1/G-CSF and LC + MSC groups versus LC + saline (1 ± 0.6, 0.7 ± 0.5, 1 ± 0.9, 1.1 ± 0.9 vs. 3.1 ± 0.8; *p < 0.05).
CONCLUSION: Local SDF-1 and/or systemic G-CSF can effectively increase BMDC homing to sites of traumatic injury in an additive way and improve wound healing. This process appears to be mediated predominantly through MSC. Additional investigations are needed to identify the optimal adjuncts to improve wound healing following severe traumatic injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825928     DOI: 10.1097/TA.0b013e318222f380

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  33 in total

1.  Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.

Authors:  A Marmotti; F Castoldi; R Rossi; S Marenco; A Risso; M Ruella; A Tron; A Borrè; D Blonna; C Tarella
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-08-08       Impact factor: 4.342

2.  Mediators of Prolonged Hematopoietic Progenitor Cell Mobilization After Severe Trauma.

Authors:  Getasha D Doobay; Elizabeth S Miller; Camille G Apple; Tyler J Loftus; Kolenkode B Kannan; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2020-12-26       Impact factor: 2.192

Review 3.  Stem cell recruitment after injury: lessons for regenerative medicine.

Authors:  Robert C Rennert; Michael Sorkin; Ravi K Garg; Geoffrey C Gurtner
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

4.  Persistent injury-associated anemia and aging: Novel insights.

Authors:  Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2018-03       Impact factor: 3.313

5.  Persistent injury-associated anemia in aged rats.

Authors:  Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr
Journal:  Exp Gerontol       Date:  2018-01-04       Impact factor: 4.032

6.  Role of macrophages in mobilization of hematopoietic progenitor cells from bone marrow after hemorrhagic shock.

Authors:  Meng Xiang; Youzhong Yuan; Liyan Fan; Yuehua Li; Aijun Li; Lianhua Yin; Melanie J Scott; Guozhi Xiao; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

7.  The effect of granulocyte-colony stimulating factor on rotator cuff healing after injury and repair.

Authors:  David Ross; Tristan Maerz; Michael Kurdziel; Joel Hein; Shashin Doshi; Asheesh Bedi; Kyle Anderson; Kevin Baker
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

8.  Persistent inflammation and anemia among critically ill septic patients.

Authors:  Tyler J Loftus; Juan C Mira; Julie A Stortz; Tezcan Ozrazgat-Baslanti; Gabriella L Ghita; Zhongkai Wang; Babette A Brumback; Ricardo F Ungaro; Azra Bihorac; Christiaan Leeuwenburgh; Frederick A Moore; Lyle L Moldawer; Scott C Brakenridge; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2019-02       Impact factor: 3.313

9.  Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli.

Authors:  Yang Yu; Rui-Xin Wu; Li-Na Gao; Yu Xia; Hao-Ning Tang; Fa-Ming Chen
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

10.  The Postinjury Inflammatory State and the Bone Marrow Response to Anemia.

Authors:  Tyler J Loftus; Juan C Mira; Elizabeth S Miller; Kolenkode B Kannan; Jessica M Plazas; Daniel Delitto; Julie A Stortz; Jennifer E Hagen; Hari K Parvataneni; Kalia K Sadasivan; Scott C Brakenridge; Frederick A Moore; Lyle L Moldawer; Philip A Efron; Alicia M Mohr
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.